Related Experiment Video
Updated: Jul 24, 2026
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
MicroRNAs as Biomarkers for Psychiatric Conditions: A Review of Current Research
Anoop Narahari1, Mariyah Hussain1, Venkatesh Sreeram1
1Drs. Narahari, Hussain, and Sreeram are from the University of Alabama, Department of Psychiatry and Behavioral sciences, Birmingham, Alabama.
Abstract:
Neural-derived exosomes can be used as diagnostic markers to screen for various psychiatric conditions. These intravenously injected exosomes carry the potential to cross the blood brain barrier and deliver miRNA molecules specifically to neurons, microglia, and oligodendrocytes in the brain, resulting in specific gene knockdown. Here the authors review and discuss the current research on microRNA molecules and the therapeutic roles they may potentially play in treating depression, bipolar disorder, and schizophrenia.
Insights
Neural-derived exosomes show promise as diagnostic markers for psychiatric conditions. These exosomes can deliver microRNA (miRNA) to the brain, offering potential therapeutic strategies for depression, bipolar disorder, and schizophrenia.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Neural-derived exosomes are investigated for their diagnostic potential in psychiatric disorders.
- Exosomes can cross the blood-brain barrier and target specific brain cells.
Purpose of the Study:
- To review current research on microRNA (miRNA) molecules within neural exosomes.
- To discuss the potential therapeutic applications of these miRNAs in treating major psychiatric conditions.
Main Methods:
- Literature review of studies on neural exosomes and miRNA.
- Analysis of miRNA delivery mechanisms and gene knockdown effects.
- Discussion of therapeutic implications for psychiatric disorders.
Main Results:
- Neural exosomes can serve as biomarkers for psychiatric conditions.
- Intravenously delivered exosomes can reach brain cells (neurons, microglia, oligodendrocytes).
- Delivered miRNAs can induce specific gene knockdown.
Conclusions:
- MicroRNA molecules within neural exosomes represent a promising avenue for psychiatric disorder diagnosis.
- Exosome-mediated miRNA delivery offers potential novel therapeutic strategies for depression, bipolar disorder, and schizophrenia.
More Related Videos
08:33Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
Published on: December 4, 2014
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021